Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv crawled time : 14:00 save search
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
presentation meeting
AbbVie Completes Acquisition of ImmunoGen
Published: 2024-02-12 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.83%
H: 0.7%
C: -0.27%
abbvie acquisition
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
Published: 2024-02-02 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: 0.0%
abbvie financial results
Trishula Therapeutics Initiates Phase 2 Trial of TTX-030, an Anti-CD39 Antibody, in First Line Metastatic Pancreatic Cancer Patients
Published: 2023-11-09 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -1.81%
H: 0.43%
C: -2.1%
ttx-030 cancer pancreatic trial therapeutics phase 2
Myasthenia Gravis Treatment Market to Grow Exponentially by 2029 | Brandessence Market Research
Published: 2023-09-18 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.7%
H: 0.0%
C: -5.11%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.72%
H: 0.13%
C: -0.93%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.02%
H: 0.18%
C: -0.78%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 0.06%
H: 0.44%
C: -0.64%
treatment research market
Fibromyalgia Treatment Market to Reach $4.6 Billion, Globally, by 2032 at 4.0% CAGR: Allied Market Research
Published: 2023-06-16 (Crawled : 14:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.75%
H: 0.14%
C: 0.14%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.6%
H: 3.2%
C: 2.9%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.03%
H: 0.29%
C: -0.59%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.41%
H: 0.26%
C: -1.77%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.6%
H: 1.62%
C: 1.42%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.4%
H: 1.07%
C: 0.72%
fibromyalgia reach treatment research market
Anti-Ageing Drugs Market to Amass Notable Gains by 2029 Says Brandessence Market Research
Published: 2023-06-15 (Crawled : 14:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.38%
H: 0.07%
C: -0.63%
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: 0.95%
H: 1.62%
C: 1.42%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.42%
H: 0.93%
C: 0.92%
research market
AbbVie to Present at the Barclays Global Healthcare Conference - March 8, 2023
Published: 2023-03-08 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.09%
H: 0.62%
C: -2.09%
global conference abbvie
BOTOX® Cosmetic (onabotulinumtoxinA) Partners with IFundWomen to Help Close the Confidence Gap for Women Entrepreneurs
Published: 2023-03-08 (Crawled : 14:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.09%
H: 0.62%
C: -2.09%
botox women
AbbVie Highlights Robust Gastroenterology Portfolio with New Analyses and Data in Inflammatory Bowel Diseases at the 18th Congress of European Crohn's and Colitis Organisation (ECCO)
Published: 2023-02-27 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.36%
H: 0.97%
C: 0.67%
abbvie
AbbVie, Capsida Set Sights on Gene Therapies for Eye Diseases
Published: 2023-02-23 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.15%
H: 1.77%
C: 0.78%
set eye
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
Published: 2022-12-06 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.05%
H: 0.22%
C: -0.19%
collaboration immunology therapeutics
United States Pharmaceutical Industry Industry Report 2022 Featuring Abbot Laboratories, AbbVie, Allergan, Amgen, BMS, Eli Lilly and Co, Gilead Sciences, GSK, Johnson & Johnson, Merck, Pfizer, & Teva
Published: 2022-11-29 (Crawled : 14:00) - prnewswire.com
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: 1.16%
H: 0.57%
C: -0.46%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.14%
C: -0.52%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.31%
H: 0.41%
C: -0.18%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.08%
H: 0.71%
C: -0.07%
report teva
U.S. FDA Accepts for Priority Review the Biologics License Application for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma
Published: 2022-11-21 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.27%
H: 2.08%
C: 1.1%
cd20 duobody treatment fda application license review
Fourth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day Most Successful One Yet
Published: 2022-11-17 (Crawled : 14:00) - prnewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.59%
H: 1.39%
C: 0.79%
botox day one
AbbVie Drops Autoimmune Program, Prioritizes Skyrizi and Rinvoq
Published: 2022-10-31 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -1.65%
H: 1.11%
C: 0.85%
skyrizi rinvoq
AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline
Published: 2022-10-20 (Crawled : 14:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.47%
H: 0.45%
C: 0.07%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.02%
H: 0.61%
C: -0.16%
immunology
Vitiligo Treatment Market Size Worth US$ 2.42 Billion With CAGR of 6.14% from 2022 to 2030 | Exclusive Report by Growth Plus Reports
Published: 2022-09-05 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.5 43.47% 1.2K
|
Health Technology
| Email alert
Add to watchlist
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
treatment report plus growth market
Despite $2B AML Deal, AbbVie Stops Early Cancer Combo Trial With I-Mab
Published: 2022-08-17 (Crawled : 14:00) - biospace.com/
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.79%
H: 0.95%
C: 0.01%
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -4.39%
H: 0.52%
C: -10.37%
aml trial cancer
Global Cystic Fibrosis Market Report 2022-2030: CFTR Modulators Segment to Dominate the Market
Published: 2022-08-02 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.0%
H: 0.6%
C: 0.6%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.1%
H: 0.58%
C: -1.18%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: 0.73%
H: 0.88%
C: -0.71%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.23%
H: 0.97%
C: -0.33%
fibrosis global report market cystic fibrosis
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.